April 25, 2026

narisnarender@gmail.com

Ultragenyx stock falls as setrusumab fails in OI studies, TD Cowen maintains Buy Source: https://www.investing.com/news/analyst-ratings/ultragenyx-stock-falls-as-setrusumab-fails-in-oi-studies-td-cowen-maintains-buy-93CH-4424408